Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Primary Objective: To compare the OS of patients with advanced HCC receiving axtitinib + best supportive care (BSC) versus (vs) placebo + BSC following failure of one prior antiangiogenic therapy.
Inclusion criteria
- Hepatocellular carcinoma (HCC)